Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07174349 · ClinicalTrials.gov registry record · Phase 4
Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery
A Phase 4 study of Urinary Retention Postoperative, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07174349: Recruiting Phase 4 study of Urinary Retention Postoperative, sponsored by Mayo Clinic.
NCT07174349 is a Phase 4 study of Urinary Retention Postoperative that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 23,453-participant average among 3 other Urinary Retention Postoperative trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07174349, a Phase 4 study of Urinary Retention Postoperative, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.
Primary Outcome
Total number of incidences of POUR (Postoperative urinary retention). POUR is defined as any of the following: estimated post-void residual (PVR) volume of urine greater than or equal to 300 mL; estimated retention urine volume of greater than or equal to 500 mL in patients unable to void; or patients experiencing discomfort or distension and unable to void with lesser residual urine volume than 500 ml.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Uroselective alpha-1-adrenergic receptor antagonist
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2028-12-31 |
| Phase | Phase 4 |
What NCT07174349 shows while recruiting
NCT07174349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 23,453-participant average among 3 other Urinary Retention Postoperative trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Urinary Retention Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07174349 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07174349 about?
NCT07174349 is a clinical study titled "Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery". The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.
What is the current status of trial NCT07174349?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2026-02-01. Estimated completion is 2028-12-31.
What conditions does trial NCT07174349 study?
This clinical trial studies the following conditions: Urinary Retention Postoperative.
What interventions are being tested in trial NCT07174349?
The interventions under investigation include: Placebo (OTHER), Uroselective alpha-1-adrenergic receptor antagonist (DRUG).
Who is sponsoring clinical trial NCT07174349?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07174349 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Retention Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
RECRUITING · Phase 2
-
NMBA Reversal and Postoperative Urinary Retention
ACTIVE NOT RECRUITING
-
Strict Need to Void After Same-day Discharge, Non-urogynecologic, Minimally Invasive Hysterectomy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI